ETHYOL

This brand name is authorized in Cyprus, France, Turkey, United States, South Africa

Active ingredients

The drug ETHYOL contains one active pharmaceutical ingredient (API):

1 Amifostine
UNII M487QF2F4V - AMIFOSTINE

Amifostine is a prodrug that is dephosphorylated by alkaline phosphatase in tissues to a pharmacologically active free thiol metabolite. This metabolite is believed to be responsible for the reduction of the cumulative renal toxicity of cisplatin and for the reduction of the toxic effects of radiation on normal oral tissues.

Read about Amifostine

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
V03AF05 Amifostine V Various → V03 All other therapeutic products → V03A All other therapeutic products → V03AF Detoxifying agents for antineoplastic treatment
Discover more medicines within V03AF05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: FR Base de données publique des médicaments Identifier(s): 62371126
Country: TR İlaç ve Tıbbi Cihaz Kurumu Identifier(s): 8680885579055
Country: US FDA, National Drug Code Identifier(s): 66220-017, 76310-017
Country: ZA Health Products Regulatory Authority Identifier(s): 30/34/0234

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.